AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lundin, P.
Right arrow Articles by Muhr, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lundin, P.
Right arrow Articles by Muhr, C.

American Journal of Neuroradiology, Vol 13, Issue 5 1279-1291, Copyright © 1992 by American Society of Neuroradiology


ARTICLES

Macroprolactinomas: serial MR imaging in long-term bromocriptine therapy

P Lundin, K Bergstrom, R Nyman, PO Lundberg and C Muhr
Department of Diagnostic Radiology, Uppsala University, Akademiska sjukhuset, Sweden.

PURPOSE: To study the changes in macroprolactinomas during long-term bromocriptine therapy by means of serial MR imaging, and to correlate the findings to the serum prolactin (S-PRL) levels. PATIENTS AND METHODS: Thirteen patients with macroprolactinomas were studied before and during bromocriptine therapy; six to 11 MR examinations were performed with a duration of follow-up of 22 to 74 months. Tumor size, extension, relationship to adjacent structures, and signal intensity patterns were evaluated. Signal intensity ratios and T2 values were calculated in areas of apparently solid tumor tissue. RESULTS: Bromocriptine effectively reduced the size of all tumors; the size reduction was already significant at 1 week, but often continued for several years. Reenlargement during therapy was seen in three cases. The development of chiasmal herniation parallel to increasing cisternal invagination into the sella was a common finding, but was not correlated to visual symptoms. Signal intensity patterns corresponding to hemorrhage, cysts or necrosis were frequently observed, and transitions from one pattern to another were common. Hemorrhage occurred mainly in tumors corresponding to high initial serum prolactin levels. After 1 year of therapy, there was a significant increase in T2 values, indicating an increased water content in residual solid tumor tissue. CONCLUSIONS: MR is valuable for follow-up in bromocriptine therapy of macroprolactinomas, and provides new information on the tumor size changes, the inner structure of the tumors, and the optic chiasm.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
R. I. Grossman
BRAIN IMAGING
AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 9 - 18.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J R Anderson, N Antoun, N Burnet, K Chatterjee, O Edwards, J D Pickard, and N Sarkies
Neurology of the pituitary gland
J. Neurol. Neurosurg. Psychiatry, June 1, 1999; 66(6): 703 - 721.
[Full Text]